Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Article ID: 316620f6-00bd-4e9f-a9b0-5bcea56bd917

Updated: 9/28/2025

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/28/2025

Measles Protection After MMR Vaccination

Approximately 5% of vaccinated persons develop a transient measles-like rash 7-10 days after vaccination, according to the Centers for Disease Control and Prevention (CDC) 1, 2, 3

Special Populations

Adults who received inadequate childhood vaccination or were vaccinated before 12 months of age may have suboptimal protection, as reported by the CDC 4
Those who received killed measles vaccine require revaccination with two doses of live MMR vaccine, as recommended by the CDC 4, 3

Vaccine Effectiveness and Risks

The benefits of vaccination far outweigh the minimal risk of vaccine failure, with natural measles infection carrying substantially higher risks of serious complications, including encephalopathy, as stated by the CDC 5

REFERENCES

1

measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the advisory committee on immunization practices (acip). [LINK]

MMWR Recommendations and Reports, 1998

2

measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the advisory committee on immunization practices (acip). [LINK]

MMWR Recommendations and Reports, 1998

3

measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the advisory committee on immunization practices (acip). [LINK]

MMWR Recommendations and Reports, 1998

4

measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the advisory committee on immunization practices (acip). [LINK]

MMWR Recommendations and Reports, 1998

5

measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the advisory committee on immunization practices (acip). [LINK]

MMWR Recommendations and Reports, 1998

← Return to Home